Association of age 40 and older with adverse outcome in metastatic testicular cancer (TC).

Authors

null

Rowan Miller

Dana-Farber Cancer Institute, Boston, MA

Rowan Miller , Sarah C Markt , Elizabeth O'Donnell , Brandon David Bernard , Laurence Albiges , Carlos Lago-Hernandez , Stephanie A. Curreri , Clair Beard , Alexi A. Wright , Christopher Sweeney

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Penile, Urethral, and Testicular Cancers

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 386)

DOI

10.1200/jco.2015.33.7_suppl.386

Abstract #

386

Poster Bd #

H22

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.

Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.

First Author: Tyler J. Nelson

Poster

2022 ASCO Genitourinary Cancers Symposium

Evaluating the discriminatory capacity of miR-371A-3P in the context of pure seminomatous testicular cancer metastases.

Evaluating the discriminatory capacity of miR-371A-3P in the context of pure seminomatous testicular cancer metastases.

First Author: Bendu Konneh

First Author: Davide Bimbatti

First Author: Maximilian Peter Johannes Karl Brandt